SPHK1 and neoplasm: With enhanced SphK and ATX and downregulated S1P lyase in tumors, S1P can promote Stat3- and Akt-mediated tumor cell growth with upregulation of Bcl-2/Bcl-xL while resisting p53-mediated apoptosis and stimulating a vicious cycle of tumorigenesis152–156.